Experience
AI Model Response Evaluator
Mercor Intelligence, Handshake AI, Ethos AI
Jun 2026 – Present | Melbourne, Victoria, Australia
Independent (contractor) Response Evaluator for frontier AI developers:
- evaluating AI model responses to biochemistry and other biology research prompts for scientific accuracy, realism, reasoning and utility to lab and research workflows
- distinguishing genuinely strong AI reasoning from shortcuts, ambiguity and/or surface-level plausibility
- evaluation of AI-generated scientific slides and documents
Independent Scientific and Medical Affairs Consultant
Self-employed
May 2025 – Present | Melbourne, Victoria, Australia
Engaged by local and global pharma and investment firms to provide insights on biologics, biosimilars, Phase II-IV development, Medical Affairs strategy, and the Australian regulatory and reimbursement environment:
- advised on ANZ trial feasibility, investigator behaviour and the operational drivers across immunology, oncology, biologics and biosimilars
- supported global teams by advising on clinical, operational, and real-world evidence trends to inform asset positioning, lifecycle strategy, and investment decisions
Senior Medical Manager
Celltrion Healthcare Australia Pty Ltd
Oct 2021 – Jan 2025 | Melbourne, Victoria, Australia
Senior Medical Affairs role leading medical strategy and scientific engagement across Immunology and Oncology portfolios in Australia and New Zealand:
- medical strategy, evidence generation and medical governance for biologics and biosimilars across immunology and oncology
- oversight of investigator-initiated studies, real-world evidence programs and company clinical trials in IBD and oncology
- leadership of national Compassionate Access programs in areas with very high unmet need
- peer-to-peer scientific engagement with gastroenterology, rheumatology, dermatology, haematology and oncology experts
- cross-functional collaboration with global and regional medical teams, and local commercial, market access and logistics teams, as well as external consultants
- development and mentoring of Medical Science Liaisons and Medical Affairs capability
- regional and global medical engagement representing the ANZ affiliates
Senior Medical Science Liaison, Immunology (IBD) – VIC/TAS/SA/WA
The Janssen Pharmaceutical Companies of Johnson & Johnson
Jul 2018 – Sep 2021 | Melbourne, Victoria, Australia
Field-based Medical Affairs role supporting the IBD biologics portfolio across product lifecycle, from pipeline to launch, through maturity and biosimilar defence: TREMFYA (guselkumab), STELARA (ustekinumab), SIMPONI (golimumab), REMICADE (infliximab):
- Led peer-to-peer scientific engagement with gastroenterologists, maintaining and expanding long-term national and regional KOL relationships, including continuity of engagement following transition from MSD
- Delivered full field medical plans during COVID lockdowns by transitioning all activities to online, completing planned engagement at ~40% under budget
- Worked with investigators to develop Australia’s first biologic dose-reduction guidelines in IBD
- Supported investigator-initiated and company-sponsored trials, including site mapping, protocol alignment, feasibility, operational readiness and investigator engagement
- Secured funding for 10 strategy-aligned KOL projects and established an “emerging KOL” development program
National Medical Science Liaison – Immunology Biosimilars
MSD Australia & New Zealand
Jun 2016 – Jun 2018 | Greater Melbourne Area
MSL work in the rheumatology, dermatology and inflammatory bowel disease (IBD) therapeutic areas during the launch of MSD’s anti-TNF biosimilars (etanercept, infliximab and adalimumab).
Earlier Experience
Medical Liaison – Respiratory & Sleep Medicine | Healthy Sleep Solutions | Jan 2014 – May 2016
Healthy Sleep Solutions, a subsidiary of Air Liquide Healthcare, is Australia’s largest provider of home-based testing and treatment for sleep apnoea. In this role, I promoted the service to doctors, including GPs, cardiologists, endocrinologists, ENT surgeons, anaesthetists, bariatric surgeons and general physicians.
Proprietor and Director | Brazcom Imports Pty Ltd | Oct 2008 – Dec 2013
Brazcom is an importer and distributor of clothing, beauty and pharmacy products. As founder, I was involved in all aspects of the company’s development, including product sourcing, logistics, sales and marketing.
Research Assistant, then PhD student, then Post-Doctoral Scientist | Lysosomal Diseases Research Unit, Women’s and Children’s Hospital | 2004 – 2009
This work examined the catabolic pathways of glycosaminoglycans in normal systems and in the deficient conditions known as Lysosomal Storage Disorders, and also identified biomarkers for the differential diagnosis of the many LSD subtypes.
PhD thesis: “Identification and characterisation of endoglycosidase activities towards dermatan sulphate by electrospray ionisation-tandem mass spectrometry”
Research Assistant | Liver Group, Royal Free and University College Medical School, University College London | 2001 – 2003
As a member of a team of scientists working towards the development of an extracorporeal bio-artificial liver device (artificial liver), my work in the Liver Group focussed on producing viable primary human hepatocyte cell lines from explant liver tissue.
Research Assistant | Lung Laboratory, Department of Human Physiology, Flinders University Medical School | 1999 – 2000
Conducted research into the synthesis, release and re-uptake of pulmonary surfactant in the lung, and studied the pathophysiology of the Acute Respiratory Distress Syndrome (ARDS).
Education
PhD, Biochemistry, Cell Biology
University of Adelaide | 2005 – 2009
BSc (Hons), Human Physiology
Flinders University | 1999
Publications
A Modern Manager’s Guide to MSL Onboarding and Development Part Two: Progressive Competency Development
The MSL | Nov 6, 2023
Sole author
A Modern Manager’s Guide to MSL Onboarding and Development. Part One: New MSL Management
The MSL | Nov 30, 2022
Switching between competing companies: an MSL survival guide
The MSL | Oct 19, 2021
Sole author
More alternative career options for scientists
Australasian Science | Dec 1, 2016
Got a PhD in science? Now what?
ABC Science | Mar 4, 2015
Sole author
Six ways to improve young scientists’ career prospects
ABC Science | Feb 26, 2014
Sole author
Hanging up their labcoats: Australia’s new brain drain
ABC Science | Jan 16, 2014
Sole author
Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats
Pediatric Research | Jan 2012
Determination of urinary oligosaccharides by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry: Application to Hunter syndrome
Analytical Biochemistry | Jul 2010
First author
Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen
Molecular Genetics and Metabolism | Feb 2010
Contributing author
Identification and characterisation of endoglycosidase activities towards dermatan sulphate by tandem mass spectrometry
University of Adelaide | PhD thesis | Sep 2009
Minimum substrate requirements of endoglycosidase activities toward dermatan sulfate by electrospray ionization-tandem mass spectrometry
Glycobiology | Dec 2008
First author
Certifications
micro1 AI Certified
micro1 | Issued Jul 2026
Artificial Intelligence (AI), Data Annotation
AI Content Specialist – Biology Subject Matter Expert
Alignerr | Issued Jul 2026
Artificial Intelligence (AI), Data Annotation
Working with Children Check
Victorian Government | Issued Jun 2018
Medicines Australia Code of Conduct
University of Tasmania | Issued Jul 2016
Pharmaceutical Industry, Medical Affairs
Business Presentation Skills Training
SecondNature International | Issued Oct 2020